The second wave of coronavirus took a massive toll on India s population. Not only did it impair the country s medical infrastructure, but it also left many gasping for breath. During such critical times, oxygen therapy became an important mode of treatment for severe COVID-19 patients, which also lead to a shortage of oxygen cylinders, concentrators and other medical equipment.
Severe COVID-19 may lead to low gray matter in brain after oxygen therapy, says study
Lower gray matter volume in frontal-temporal network of brain has been associated with a higher-level of disability among COVID-19 patients, even six months after hospital discharge, study revealed
BusinessToday.In | June 10, 2021 | Updated 16:13 IST
India has been badly hit by coronavirus, leading to exponential rise in total cases and subsequent deaths. Many patients who recovered were also diagnosed with black fungus
COVID-19 patients who receive oxygen therapy or experience fever may witness gray matter volume reduction in the frontal-temporal network of the brain, says a new study conducted by researchers at Georgia State University and the Georgia Institute of Technology. Gray matter is vital for processing information in the brain and its abnormality may affect how well neurons function and communicate.
New Delhi: A Webinar on ‘Oxygen Enrichment Unit- Seeking MSME partners for solving the Oxygen Crisis’ was organised by MSME-DI, Jammu in association with CSIR-CMERI on 4thJune2021 for the MSMEs of the region. The Webinar was attended by Mr. Shahid Ka